The announcement from the FDA on Aug. 30, 2023, that it would delay full enforcement of the prescription tracking requirements of the Drug Supply Chain Security Act (DSCSA) from Nov. 27, 2023, to the same date in 2024, no doubt came as a relief to many health-system pharmacies struggling to hit the DSCSA’s key compliance points.
“The stabilization period will accommodate an additional year, until Nov. 27, 2024, to allow trading partners to implement, troubleshoot and